MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    MicroRNA Expression in the Diagnosis of Parkinson’s Disease

    J. Roy, D. Guévremont, A. Garvey, N. Cutfield, J. Williams (Dunedin, New Zealand)

    Objective: To identify plasma-derived microRNAs (miRNAs) to serve as potential diagnostic and prognostic biomarkers of Parkinson’s disease (PD). Background: PD is characterized by the progressive…
  • 2019 International Congress

    Enhancing the Proteasomal Degradation of Alpha Synuclein: “The Hallmark” to attenuating the Progression of Parkinson’s Disease

    B. Adebisi, M. Adeleke (Osogbo, Nigeria)

    Objective: The research aimed at preventing the accumulation of Alpha Synuclein in order to prevent it's accumulation.  It is imperative that we also establish that…
  • 2019 International Congress

    Multiple System Atrophy – perspectives in diagnosis?

    P. Alster, D. Koziorowski, L. Królicki, A. Friedman (Warsaw, Poland)

    Objective: The aim of this study was to study the role of perfusion single photon emission computed tomography (SPECT) in the examination of multiple system…
  • 2019 International Congress

    “Familial imprint” of Parkinson disease: the siblings’ cohort of PROPAG-AGEING

    L. Baldelli, F. Provini, S. Schade, S. Jesús, P. Gómez-Garre, L. Sambati, S. Schreglmann, G. Calandra Buonaura, C. Halsband, M. Carrion, K. Bhatia, P. Mir, P. Cortelli, B. Mollenhauer, C. Trenkwalder, PPG. Propag-Ageing Consortium (Bologna, Italy)

    Objective: To verify if non-affected siblings (Sibs) of PD patients share candidate PD biomarkers in comparison with de-novo PD patients (PD) and healthy controls (HC).…
  • 2019 International Congress

    Therapeutic management of complicated Parkinson’s disease: clinical application of the Motor Fluctuation Indices

    R. Bonomo, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: To evaluate the usefulness of the Motor Fluctuation Indices to assess clinically relevant change in motor fluctuations in advanced Parkinson’s disease (PD) patients after…
  • 2019 International Congress

    Contribution of pedunculopontine nucleus cholinergic neurons to L-DOPA-induced dyskinesia and PD motor deficits in hemi-parkinsonian rats

    N. Chambers, J. Sergio, C. Saito, K. Lanza, C. Bishop (Binghamton, NY, USA)

    Objective: To determine if chemogenetic and pharmacological modulation of pedunculopontine nucleus (PPN) cholinergic neurons can alter L-DOPA-induced dyskinesia and gait deficits in hemi-parkinsonian rats. Background:…
  • 2019 International Congress

    Nutritional status in patients with Parkinson’s disease and its relationship with the motor phenotype.

    R. Cruz, J. Balderas, C. Navarro, L. Zuazua, M. Rodriguez, A. Cervantes (Mexico City, Mexico)

    Objective: To determine the nutritional status in patients with Parkinson's disease and to relate it to the motor phenotype. Background: Parkinson disease (PD) is a…
  • 2019 International Congress

    Long-Term Effects of LPS and Alcohol in Rats: A Model of Neuro-Degenerative Disease

    M. Schiess, M. Doursout, J. Campo, Z. Peng, A. Sundaresan, S. Umar (Lawrence, KS, USA)

    Objective: We postulate alterations of the intestinal barrier (or leaky guts) enhances inflammation, as well as the production of alpga (α)-synuclein which has characteristic pathological…
  • 2019 International Congress

    Interleaving stimulation in Parkinson’s disease: interesting to whom?

    C. França, E. Barbosa, R. Iglesio, M. Teixeira, R. Cury (São Paulo, Brazil)

    Objective: Overview our patients’ experience with ILS and explore clinical scenarios in which ILS should be considered when programming DBS in PD patients. Background: Interleaving…
  • 2019 International Congress

    Functional Limits of Stability and Standing Balance in people with and without Freezing of Gait

    N. Hasegawa, K. Maas, V. Shah, P. Carlson-Kuhta, J. Nutt, F. Horak, T. Asaka, M. Mancini (Portland, OR, USA)

    Objective: To investigate whether Freezing of Gait (FoG) impacts functional Limits of Stability (fLoS) and postural sway during quiet stance and dynamic balance in a…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley